| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 680.86 | 53.7% | 12.6% |
| Total Income | 685.44 | 53.9% | 12.6% |
| Expenditure | 185.25 | 21.7% | 166.1% |
| PBT | 493.79 | 60.5% | 8.4% |
| Net Profit | 418.00 | 62.3% | 45.5% |
| OPM | 82.36% | 6.69pp | 13.94pp |
| NPM | 60.98% | 13.62pp | 39.02pp |
| EPS | 4.92 | 62.3% | 89.1% |
Detailed report is being prepared.
On track for mid-teen PAT growth; watch for investment income sustainability
After a 17.5% YoY surge in Q1, Street expects Authum to extend earnings momentum in Q2 as investment income stabilizes and lending revenue benefits from recent capital deployments. Couple of operational moves — NCLT approvals for resolution plans, ₹100 Cr equity flip — set the backdrop.
The setup: investment income on the mend
Authum Investment's Q1 beat expectations with consolidated PAT of ₹1,108 Cr, up 17.5% YoY, riding a rebound in investment income as prior-period volatility settled. The company's FY27 guidance implies 15–20% PAT growth for the full year. Q2 will test whether that momentum holds — and whether investment income proves to be a structural tailwind or a quarterly bounce.
~₹1,080–1,150 Cr
Mid-15–20% YoY growth from Q2 FY26 base; anchored to FY27 guidance and Q1 trajectory
~₹1,450–1,550 Cr
Revenue from operations plus investment income; watch for revenue mix stability
Signal of recovery
Q1 lending revenue fell 68% YoY; Q2 should show traction from recent deployments and NCLT acquisitions
Stability expected
Lower interest costs versus prior year supports profitability; watch for operating leverage
What a strong print vs. a weak one looks like
A strong Q2: Consolidated PAT in the ₹1,130–1,150 Cr range (upper end of 15–20% growth); lending revenue showing >20% recovery from Q1's depressed base; investment income normalizing to a run-rate ₹100–150 Cr per quarter; operating margins stable or slightly expanding. Total income growth +15% YoY or better signals disciplined capital deployment.
A weak Q2: Consolidated PAT below ₹1,080 Cr (low-single-digit YoY growth or flat); investment income showing mean-reversion into <₹50 Cr or turning negative; lending revenue failing to recover, signaling execution delays on recent NCLT assets or Vibhav Energy deployment. Total income decline YoY would raise questions on visibility into FY27's mid-teen guidance.
Is the company on track for FY27 guidance?
Trajectory through Q1: Authum delivered ₹1,108 Cr in Q1 PAT, consistent with mid-teen growth if sustained across the remaining three quarters. That means Q2–Q4 should average ~₹1,100–1,150 Cr each to hit full-year guidance. Q1's 17.5% growth is slightly ahead of the Street's 15–20% midpoint, leaving room for moderation.
The swing factor: Investment income. Q1's rebound was material (₹500+ Cr contribution to total income, net of lending's cratering). If that normalizes to a lower run-rate in Q2–Q4, the company must show lending revenue recovery or new asset monetization to defend the guidance. Recent NCLT wins (Wind World resolution plan, consortium arrangements) and the ₹100 Cr equity flip into Vibhav Energy suggest management is actively repurposing capital, but execution risk is real.
No full-year forecast has been formally announced; guidance is inferred from management commentary and analyst consensus. A weak Q2 would not disqualify FY27 targets but would compress the confidence margin.
What the Street says
Since last quarter: key filings & events
Jul 20, 2026
Q1 FY27 results: ₹1,108 Cr PAT, +17.5% YoY
Sets bar for Q2–Q4; investment income swing is the driver
Jul 22–25, 2026
Income Tax search operations at corporate office (concluded Jul 25)
Regulatory overhang cleared; no ongoing investigation flagged
Jul 28, 2026
NCLT approval (Ahmedabad Bench) for Wind World resolution plan
Consortium win with INEL; deployment of capital into energy asset recovery; execution risk on integration
Oct 13, 2026
Wind World resolution plan implementation completed
Asset now operational; earnings contribution expected in Q3–Q4 or later depending on hold period
Oct 10, 2026
₹100 Cr equity conversion into Vibhav Energy
ICD → equity swap; signals confidence in Vibhav's long-term value; valuation impact and dividend yield to watch
Oct 28, 2026
Board meeting announced for Nov 3 to approve Q2 results
Q2 results expected on/around Nov 3
Routine items: AGM held Sept 28, 2026 (directors re-appointed); annual report filed; trading window closures per normal corporate governance. No insider trading, pledge, or corporate action anomalies flagged.
Valuation & risk
The bull case: If investment income stabilizes at a steady run-rate and lending revenues recover as recent NCLT and equity deployments mature, the company could exceed 15–20% PAT growth. At FY27 earnings of ~₹4,400–4,500 Cr (implied from mid-teen growth from the FY26 base), a ₹545–570 target implies ~12–13x forward earnings, a reasonable multiple for a financial services player on a recovery arc.
The bear case: Investment income proves to be a cyclical windfall that mean-reverts sharply in Q2–Q3, leaving the company dependent on slower-growing lending revenue. Execution delays on NCLT assets or Vibhav Energy's payoff timeline extend the earnings recovery. Near-term regulatory overhang (income tax search concluded but no legal closure communicated) could resurface. At current valuations, a Q2 miss would trigger a re-rating toward the bear target of ₹492.
The close
Authum is mid-cycle in a multi-quarter recovery arc. Q1 set an optimistic tone with 17.5% YoY growth, but the real test is whether that represents a new run-rate or a cyclical peak in investment income. Q2 will confirm the sustainability of the ₹1,100+ Cr quarterly PAT level that underpins the Street's 15–20% full-year growth assumption.
Three things to watch on Nov 3: (1) Investment income: Is it normalizing to a ₹100–150 Cr range per quarter, or rolling over? (2) Lending revenue: The 68% YoY decline in Q1 must show a sharp reversal in Q2 for confidence in FY27's guidance to hold. (3) Operating margin: With interest costs lower, watch for leverage into the bottom line — a stable or expanding margin vs. Q1 validates the cost-savings thesis and supports the ₹545–570 analyst targets.